S-phase modulation by irinotecan: pilot studies in advanced solid tumors. [electronic resource]
Producer: 20051129Description: 447-54 p. digitalISSN:- 0344-5704
- Adenocarcinoma -- drug therapy
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biopsy
- Camptothecin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Cyclin A -- analysis
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Gastrointestinal Neoplasms -- drug therapy
- Humans
- Irinotecan
- Male
- Maximum Tolerated Dose
- Respiratory Tract Neoplasms -- drug therapy
- S Phase -- drug effects
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.